2024
Mechanisms of therapeutic change after psychedelic treatment in OCD
Maloney G, Ching T, Kichuk S, Pittenger C, Kelmendi B. Mechanisms of therapeutic change after psychedelic treatment in OCD. Psychiatry Research 2024, 336: 115907. PMID: 38615521, PMCID: PMC11190873, DOI: 10.1016/j.psychres.2024.115907.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderMechanisms of therapeutic changeAversive eventsImagery rescriptingPsychedelic treatmentPsychotherapeutic treatmentPsychotherapeutic frameworkSymptom reductionTherapeutic changePsychotherapyNegative emotionsPsychological mechanismsCore beliefsPilot dataNovel treatmentRescriptingEmotionsDisordersSymptomsReprocessingTreatmentBeliefsResistance to first-lineIndividualsIntervention
2022
MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial
Ching T, Williams M, Reed S, Kisicki M, Wang J, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial. Journal Of Humanistic Psychology 2022, 64: 692-722. DOI: 10.1177/00221678221076993.Peer-Reviewed Original ResearchPosttraumatic stress disorderOpen-label trialTreatment-resistant posttraumatic stress disorderStress disorderPTSD symptomsPrevious clinical trialsPTSD symptom reductionInterpretative phenomenological analysisMechanism of actionPromising efficacyClinical trialsSymptom recoveryTreatment approachesSymptom reductionSymptom changeParticipants of colorTrialsTherapySymptomsDisordersAdditional aimMechanisms of changeParticipantsAdditional effectCase profiles